MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

Marketable debtsecurities, at fair value$186,314K Accounts receivable, net$87,302K Cash and cashequivalents$78,362K Prepaid expenses andother current assets$34,347K Inventory$6,356K Total current assets$392,681K Intangible assets, net$110,038K Long-term inventory$30,698K Operating lease right ofuse assets$9,668K Other assets$8,476K Property and equipment,net$3,627K Total assets$555,188K Total liabilities andstockholders' equity$555,188K Total liabilities$456,460K Total stockholders'equity$98,728K Accumulated deficit-$1,509,815K Accumulated othercomprehensive loss-$1,062K Convertible debt$312,079K Total currentliabilities$125,437K Operating leaseliabilities, less current...$9,566K Other non-currentliabilities$9,378K Additional paid-in capital$1,609,596K Common stock 0.0001 parvalue 200,000,000...$9K Accrued expenses$104,408K Accounts payable$12,912K Operating leaseliabilities, current portion$6,017K Other currentliabilities$2,100K
Balance Sheet

Travere Therapeutics, Inc. (TVTX)

Travere Therapeutics, Inc. (TVTX)

source: myfinsight.com